FDA Proposes Changes to Labeling Regulations for Biological Products

Summary

The FDA is proposing to relax labeling requirements for biological products, allowing distributors' names to be prominently displayed alongside manufacturers', in an effort to streamline manufacturing, packaging, and labeling processes and align with regulations for drugs approved under the Federal Food, Drug, and Cosmetic Act.